NCT07321340 Insole Optimization for Rheumatoid Arthritis Patients
| NCT ID | NCT07321340 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Condition | Rhumatoid Arthisis |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2026-06-02 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2026-06-02 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Rheumatoid arthritis affects 0.5% of the population, often leading to foot deformities and pain that are difficult to treat. Management is based on controlling inflammation, adapting footwear and using custom-made insoles, all of which have proven effective. The aim of this research is to build a digital model of plantar pressures based on CT scans, in order to optimize orthopedic insoles. The study will analyze the gait of patients with and without standard insoles to identify mechanical criteria correlated with pain. The ultimate aim is to design optimized insoles, validated by a new gait analysis.
Eligibility Criteria
Inclusion Criteria: * Patients with rheumatoid arthritis according to 2010 ACR/EULAR criteria * RA at low activity level according to DAS28≤3.2 * Patient with mechanical forefoot involvement on walking and improved by foot orthoses. Exclusion Criteria: * Patients with a contraindication to a bone scan * Patients with neurological gait disorders that interfere with gait analysis * Exclude particularly protected persons: * Pregnant women, parturients, nursing mothers; * Persons deprived of liberty, hospitalized without consent, hospitalized for purposes other than research; * Minors;
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07321340 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Rhumatoid Arthisis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07321340 currently recruiting?
Yes, NCT07321340 is actively recruiting participants. Contact the research team at hubert.marotte@chu-st-etienne.fr for enrollment information.
Where is the NCT07321340 trial being conducted?
This trial is being conducted at Saint-Etienne, France.
Who is sponsoring the NCT07321340 clinical trial?
NCT07321340 is sponsored by Centre Hospitalier Universitaire de Saint Etienne. The trial plans to enroll 10 participants.